Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial
M. J. Ryan(King's College London), Rod Stables(Liverpool Heart and Chest Hospital), Nick Curzen(University Hospital Southampton NHS Foundation Trust), Julian Strange(NIHR Bristol Cardiovascular Biomedical Research Unit), Vasileios F. Panoulas(Imperial College Healthcare NHS Trust), Divaka Perera, Tim Clayton(London School of Hygiene & Tropical Medicine), Haseeb Rahman(Guy's and St Thomas' NHS Foundation Trust), Lynn Laidlaw(London School of Hygiene & Tropical Medicine), Peter O’Kane(Royal Bournemouth Hospital), Sohail Q. Khan(Queen Elizabeth Hospital Birmingham), Saad Ezad(King's College London), Roshan Weerackody(Barts Health NHS Trust), Matthew Dodd(London School of Hygiene & Tropical Medicine), Stephen P. Hoole(Papworth Hospital NHS Foundation Trust), Farzin Fath‐Ordoubadi(University of Manchester), Richard Evans(University of London), Alan Bagnall(Freeman Hospital), Ian Webb(Kings Health Partners)
Cited by 18
Related Papers
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
|The Lancet|2018|733
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2022|566
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
|American Journal of Respiratory and Critical Care Medicine|2005|381
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
|American Journal of Respiratory and Critical Care Medicine|2005|367